Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
- 24 December 2009
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (8), 1262-1272
- https://doi.org/10.1016/j.biocel.2009.12.017
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transitionGynecologic Oncology, 2010
- Minireview: Epigenetic Changes in Ovarian CancerEndocrinology, 2009
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- Genetic Analysis of Cancer-Implicated MicroRNA in Ovarian CancerClinical Cancer Research, 2008
- Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the normJournal of Cellular Physiology, 2007
- The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarityOncogene, 2007
- Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatmentMolecular Cancer Therapeutics, 2007
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Ovarian Surface Epithelium: Biology, Endocrinology, and PathologyEndocrine Reviews, 2001